UBS Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,005
| Closed | -$159K | – | 9099 |
|
|
2020
Q3 | $159K | Sell |
3,005
-750
| -20% | -$46.3K | ﹤0.01% | 4927 |
|
|
2020
Q2 | $230K | Sell |
3,755
-1,940
| -34% | -$112K | ﹤0.01% | 4710 |
|
|
2020
Q1 | $322K | Sell |
5,695
-12,148
| -68% | -$692K | ﹤0.01% | 4341 |
|
|
2019
Q4 | $1.02M | Buy |
17,843
+1,900
| +12% | +$101K | ﹤0.01% | 4199 |
|
|
2019
Q3 | $853K | Buy |
15,943
+4,033
| +34% | +$235K | ﹤0.01% | 4097 |
|
|
2019
Q2 | $711K | Buy |
11,910
+3,325
| +39% | +$209K | ﹤0.01% | 4019 |
|
|
2019
Q1 | $535K | Buy |
8,585
+4,800
| +127% | +$318K | ﹤0.01% | 4022 |
|
|
2018
Q4 | $229K | Buy |
3,785
+507
| +15% | +$30.3K | ﹤0.01% | 4860 |
|
|
2018
Q3 | $192K | Buy |
3,278
+633
| +24% | +$32.3K | ﹤0.01% | 5099 |
|
|
2018
Q2 | $119K | Sell |
2,645
-1,789
| -40% | -$76.9K | ﹤0.01% | 5319 |
|
|
2018
Q1 | $197K | Sell |
4,434
-1,208
| -21% | -$50.7K | ﹤0.01% | 4793 |
|
|
2017
Q4 | $244K | Sell |
5,642
-722
| -11% | -$32.5K | ﹤0.01% | 4781 |
|
|
2017
Q3 | $296K | Sell |
6,364
-597
| -9% | -$28.6K | ﹤0.01% | 4577 |
|
|
2017
Q2 | $344K | Buy |
6,961
+757
| +12% | +$39.7K | ﹤0.01% | 4390 |
|
|
2017
Q1 | $340K | Sell |
6,204
-761
| -11% | -$40.3K | ﹤0.01% | 4299 |
|
|
2016
Q4 | $388K | Buy |
6,965
+1,207
| +21% | +$58K | ﹤0.01% | 4304 |
|
|
2016
Q3 | $263K | Buy |
5,758
+196
| +4% | +$7.87K | ﹤0.01% | 4349 |
|
|
2016
Q2 | $222K | Buy |
5,562
+219
| +4% | +$8.02K | ﹤0.01% | 4483 |
|
|
2016
Q1 | $186K | Buy |
5,343
+841
| +19% | +$30.9K | ﹤0.01% | 4537 |
|
|
2015
Q4 | $194K | Sell |
4,502
-889
| -16% | -$44.5K | ﹤0.01% | 4695 |
|
|
2015
Q3 | $234K | Buy |
5,391
+2,882
| +115% | +$156K | ﹤0.01% | 4503 |
|
|
2015
Q2 | $129K | Buy |
2,509
+2,350
| +1,478% | +$100K | ﹤0.01% | 5214 |
|
|
2015
Q1 | $6K | Sell |
159
-76
| -32% | -$2.98K | ﹤0.01% | 8036 |
|
|
2014
Q4 | $9K | Buy |
+235
| New | +$8.97K | ﹤0.01% | 8513 |
|
Other funds holding BSTC
UBS Group's BSTC Position: Q4 2020 in Review
UBS Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 3,005 shares — an estimated $159K sold.
UBS Group first reported a position in BSTC in Q4 2014 and held it in 24 quarters. The position peaked at $1.02M in Q4 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- UBS Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- UBS Group sold 3,005 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $159K.
- UBS Group first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and held it in 24 quarters.
- UBS Group's BioSpecifics Technologies Corp. position peaked at $1.02M in Q4 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.